© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Bezafibrate belongs in the class of fibric acid derivatives, used mainly for lowering lipid levels in the blood. Many specialty and generic drug manufacturers rely on this substance as a key raw material for pharmaceuticals aimed at managing hyperlipidemia. In direct use, doctors often prescribe bezafibrate to combat high cholesterol and triglyceride levels, making it a staple in modern healthcare strategies fighting against heart disease and metabolic syndrome.
Tablets and capsules count as the most common forms of bezafibrate found in the marketplace. These dose forms make use of the compound’s stability and moderate solubility, helping facilitate absorption in the digestive tract. Dosages typically range from 200 mg to 400 mg per tablet or capsule, matched to patient needs and corresponding treatment protocols. Pharmaceutical developers routinely use bezafibrate as a building-block ingredient for finished drugs designed to treat lipid disorders. The use of this substance remains tightly regulated, so quality control of its physical and chemical properties becomes vital from batch to batch.
Bezafibrate usually appears as a white or almost white crystalline powder, providing a reliable visual indicator during quality checks. Its molecular formula, C19H20ClNO4, reveals a foundation comprised of carbon, hydrogen, chlorine, nitrogen, and oxygen atoms, designed for efficient biological activity within the human body. With a molecular weight of 361.8 g/mol, bezafibrate balances compactness with functional complexity. The density typically measures around 1.2 g/cm³, a feature important when preparing solid oral forms or integrating with other excipients.
Examining its structure, this compound packs interconnected aromatic rings along with carboxylic and amide functional groups, which play direct roles in both efficacy and solubility. Though not the easiest to dissolve in water, bezafibrate responds better in organic solvents such as ethanol and methanol—handy information for manufacturers working with a range of solvent systems during synthesis or formulation processes. Solid at room temperature, bezafibrate retains its shape and purity during long-term storage, reducing risk of unwanted degradation.
Bezafibrate is sourced in several physical forms for use in industrial and lab settings. While powder is most widespread for practical blending and dosing precision, some suppliers also offer flakes, pearls, and even crystals, depending on downstream processing needs. In my experience working alongside chemical procurement teams, these forms rarely cause confusion because strict material data sheets specify not only the type, but also important features like purity—typically not less than 98%—and particle size, which plays a large role in consistent dissolution rates.
Large quantities ship in tightly sealed, light-resistant packaging to block contamination and avoid absorption of ambient moisture. Material safety data sheets (MSDS) instruct on temperature control, emphasizing the need to store bezafibrate below 30°C and to avoid direct sunlight or humid conditions that might compromise the chemical’s stability and efficacy.
According to international trade standards, bezafibrate often carries Harmonized System (HS) code 2934999099 for customs and regulatory tracking in many jurisdictions. This code classifies bezafibrate among “other heterocyclic compounds,” keeping administrative records both transparent and traceable for exporters and importers. On the safety side, bezafibrate counts as hazardous under certain handling conditions, particularly in concentrated bulk. Direct skin, eye, or respiratory exposure should be avoided, as the compound may cause irritation or sensitization in susceptible individuals. Factories implementing large-scale synthesis or formulation train employees to use suitable personal protective equipment, including gloves, masks, and eye protection. Environmental releases require careful management to avoid contamination of waterways or soil since bezafibrate residues may persist and display mild toxicity to aquatic organisms.
Manufacture of bezafibrate demands access to precursor chemicals derived from petrochemicals and aromatic hydrocarbons, along with high purity reagents for each chemical step. My past experience with supply chain disruptions during raw material shortages highlighted just how important it is to secure trusted relationships with suppliers and maintain robust protocol for incoming quality checks. This practice saves pharmaceutical companies trouble down the road by pinpointing contamination or off-specification batches before they ever reach production. Secure warehousing, regular audits, and coordinated logistics reduce variability in product quality, an approach further reinforced by international regulations such as Good Manufacturing Practices (GMP).
In the manufacturing sector, improper storage or careless disposal of bezafibrate and its byproducts puts workers, communities, and ecosystems at unnecessary risk. Waste streams containing traces of bezafibrate require pre-treatment and responsible disposal in accordance with local and international environmental standards. Over the years, continued research on the environmental impact of pharmaceuticals has shown that residues in waterways can influence natural biological processes—yet with proper containment, these impacts can be minimized. Incineration at approved facilities or chemical neutralization under controlled conditions both serve as effective options for waste management.
Improved process controls—ranging from high precision manufacturing analytics to automation and real-time monitoring—stand out as necessary solutions for maintaining product integrity. The pharmaceutical sector invests heavily in next-generation quality assurance systems to reduce variability, catch contaminants, and ensure every dose of bezafibrate delivers predictable therapeutic results. On the worker safety front, providing up-to-date safety training, spill management plans, and medical support in case of exposure contributes to a workplace culture that puts human health ahead of speed or convenience. Transparent supply chains help track provenance and minimize risks rooted in raw material substitutions or shortages, bringing stability to a market where margin for error is slim.
